SLC5A7
SLC5A7 (solute carrier family 5 member 7), also known as high affinity choline transporter 1, hCHT, CHT1 or ChT, is a sodium- and chloride-dependent symporter that takes up choline into cholinergic nerve terminals. This uptake is the rate-limiting step in acetylcholine synthesis. Browse Assay Genie's current range of SLC5A7 research reagents below, or read on for the biology behind the target.
SLC5A7 is a high-affinity, Na(+)-coupled choline transmembrane symporter. It works as an electrogenic, voltage-dependent transporter with variable charge-to-choline stoichiometry. Choline uptake and choline-induced current also depend on Cl(-), which is likely to act as a regulatory ion rather than a cotransported one. By taking choline from the synaptic cleft into presynaptic nerve terminals after neurotransmitter release, the transporter plays a critical role in acetylcholine (ACh) synthesis. High-affinity choline transport through SLC5A7 in cholinergic neurons is the rate-limiting step in ACh production, and so supports communication by subsequent action potentials.
The protein is found mainly in intracellular organelles of the presynaptic terminal, including synaptic vesicle membranes, and in early endosome membranes. In response to neuronal activity it is translocated in its active form to the presynaptic plasma membrane. In line with this, NCBI Gene notes that increased choline uptake follows from a greater density of the protein in synaptosomal plasma membranes after depolarisation of cholinergic terminals. UniProt places it in the sodium:solute symporter (SSF) family, and HGNC lists it in the solute carrier family 5 gene group. Mouse and rat both carry an ortholog named Slc5a7.
The gene was formerly named solute carrier family 5 (choline transporter), member 7, and solute carrier family 5 (sodium/choline cotransporter), member 7. Dysfunction of cholinergic signalling has been implicated in depression, attention-deficit disorder and schizophrenia. An allelic variant of the SLC5A7 gene is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA, and alternative splicing yields multiple transcript variants.
SLC5A7 mediates the rate-limiting step of acetylcholine synthesis, making it a central subject in studies of cholinergic signalling at presynaptic terminals.
The transporter moves from intracellular organelles to the plasma membrane in response to neuronal activity, which makes it a model for activity-dependent trafficking.
Cholinergic dysfunction has been implicated in depression, attention-deficit disorder and schizophrenia, linking choline transport to these conditions.
An allelic variant of SLC5A7 is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA, so the gene is relevant to motor neuron disease studies.
SLC5A7 is a high-affinity, Na(+)-coupled choline symporter that takes choline from the synaptic cleft into presynaptic terminals of cholinergic neurons. This uptake is the rate-limiting step for acetylcholine synthesis. Transport is electrogenic and voltage-dependent, and Cl(-) acts as a likely regulatory ion.
SLC5A7 is also called high affinity choline transporter 1, hCHT, CHT1 and ChT. Earlier HGNC names were solute carrier family 5 (choline transporter), member 7, and solute carrier family 5 (sodium/choline cotransporter), member 7. NCBI Gene notes that alternative splicing produces multiple transcript variants.
Mouse and rat each have an ortholog called Slc5a7; check the datasheet of any product for its validated reactivity. An allelic variant of human SLC5A7 is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA, and cholinergic dysfunction is implicated in several neuropsychiatric disorders.
Other solute carrier transporters, including neurotransmitter and ion cotransporters relevant to synaptic biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9GZV3; product specifications from Assay Genie datasheets.